May 13, 2024 Experience RxSight $115 million follow-on offering The stock is listed on the Nasdaq Global Market
May 10, 2024 Experience Oculis Holding $100 million at-the-market offering The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
May 9, 2024 Experience Visa Class B stockholder liquidity program and $100 billion exchange offer We advised Visa on the design and implementation of its Class B stockholder liquidity program and inaugural exchange offer
May 8, 2024 Experience ADC Therapeutics $105 million follow-on offering We advised ADC Therapeutics on its offering of shares and pre-funded warrants
April 29, 2024 Experience UMB Financial $2 billion acquisition of Heartland Financial We are advising UMB on the acquisition and a $201.6 million stock offering
April 23, 2024 Experience TScan Therapeutics $150 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Market
April 23, 2024 Experience Cohen & Steers $100 million at-the-market offering The shares are listed on the NYSE
April 22, 2024 Experience Intra-Cellular Therapies $500 million stock offering The shares are listed on the Nasdaq Global Select Market
April 17, 2024 Experience Galaxy C$169.4 million offering of ordinary shares We advised Galaxy on its offering